Sugar Editorial Picks
Jan 09, 2009 -
H.R. 4040, the Consumer Product Safety Improvement Act (CPSIA), was passed by Congress last year and requires retailers to test merchandise for lead. This pertains to any item for children 12 and under including toys, clothes and jewelry.
- 13 Comments
Other Search Results
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- General Dietary Guidelines...
- Major Food Components
- Weight Control for Type 2 D...
- Heart-Healthy Diets
- Diabetic Exchange Lists
- Exercise
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Lifestyle Changes Essential for People at Risk for Diabetes
Lifestyle interventions that include weight loss, dietary changes, and increased physical activity can definitely help prevent or delay the progression to diabetes among at-risk people, suggest several recent studies. Weight loss through diet and exercise is especially important for overweight people with pre-diabetes.
Grain Fiber Important for Diabetes Prevention
Eating whole-grain, fiber-rich, cereal foods may help reduce the risk of developing type 2 diabetes, indicates a 2007 study in the Archives of Internal Medicine.
- 5 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Carotenoids
- Phytochemicals
- Healthy Foods
- Dietary Health Benefits
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Cancer
Growing evidence suggests that vitamins and micronutrients, especially from foods, may play important roles in the prevention or treatment of certain cancers:
- One study found that the risk of prostate cancer risk dropped as consumption of vegetables high in vitamin C, such as broccoli and bell peppers, rose.
- A diet high in cruciferous vegetables has been found to reduce the risk of kidney cancer; low consumption of cruciferous vegetables increases the risk.
On the other hand, high amounts of folic acid (a B vitamin) may be associated with colorectal cancer, and beta-carotene supplements are associated with increased lung cancer risk in smokers and people exposed to asbestos.
Macular Degeneration
In 2007, the National Eye Institute recommended that people with intermediate or advanced macular degeneration in one eye take a vitamin formula shown to reduce the risk of macular degeneration in the other eye by 25%. The formula contains vitamin C, vitamin E, beta-carotene, and zinc.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Blemishes
- Risk Factors
- Prevention
- Treatment
- Resurfacing Treatments
- Implant Procedures
- Plastic Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Smoking and Skin Damage
- The skin of smokers ages more rapidly than the skin of non-smokers, even in areas of the body not exposed to sunlight, according to a 2007 study. Women in the study who smoked also had much lower levels of vitamin E secretions in their skin. Vitamin E may protect the skin from sun damage.
- There may be an association between smoking and higher frequency of a type of acne (noninflammatory acne) in adult women, according to a European study.
Antioxidants and Your Skin
- A study in the Journal of Nutrition found that a combination of antioxidants and trace elements supplementation raises the risk of skin cancer in women, but not in men.
Ultraviolet Radiation
- Overall, exposure to ultraviolet radiation from sunlight (radiation referred to as UVA or UVB) accounts for about 90% of the symptoms of premature skin aging.
- UVB primarily affects the outer skin layers.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Prevention
- Symptoms
- Diagnosis
- Medications
- Stages
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Alzheimer’s Disease Toll Increasing
More than 5 million Americans now have Alzheimer’s disease, and the number could increase to 16 million by mid-century, according to a 2007 report from the Alzheimer’s Association.
New Drug Indication
In 2006, the FDA expanded the use of donepezil (Aricept) to include treatment of people with severe dementia associated with Alzheimer’s disease. Donepezil was previously approved only for people with mild-to-moderate dementia.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Recommended Exercise Method...
- Exercise's Effects on the H...
- Exercise's Effects on Diabe...
- Exercise's Effects on Bones...
- Exercise's Effects on the L...
- Exercise's Effects on Weigh...
- Exercise's Effects on Other...
- Complications
- Motivation
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Chronic Conditions and Exercise:
- A new study found that aerobic and resistance training significantly reduced fatigue in men undergoing radiation treatments for prostate cancer. Fatigue is a common side effect of such treatments.
- Doctors at the Mayo Clinic found that exercise improves the physical and emotional well-being of patients with Alzheimer's disease. The patients exercised for as little as 60 minutes each week.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Screening Tests
- Treatment
- Lifestyle Changes
- Medications
- Long-Term Complications
- Emergency Complications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- Sitagliptin (Januvia), the first in a new class of diabetes drugs called DPP-4 inhibitors, was approved in 2006.
- Janumet, a 2-in-1 pill that contains both sitagliptin and metformin, was approved in 2007.
- These drugs are taken by mouth and may be more convenient for patients than exenatide (Byetta), a similar drug. DPP-4 inhibitors do not cause weight gain and may pose a lower risk for hypoglycemia than some other diabetes drugs.
Drug Safety Alert
Rosiglitazone (Avandia) may significantly increase the risk for heart attack, indicates a review published in the Journal of the American Medical Association. In 2007, a panel of experts from the Food and Drug Administration (FDA) agreed the drug increases the risk of heart attacks -- but concluded it should remain on the market.
- 4 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Types of Psoriasis
- Causes
- Risk Factors
- Diagnosis
- Treatment
- Topical Medications
- Systemic Medications
- Phototherapy
- Managing Psoriasis
- Outlook
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Treatment
Psoriasis that develops on the hands or feet is often very difficult to treat. However, an advanced clinical trial showed that a medication called efalizumab (Raptiva) effectively cleared or nearly cleared moderate-to-severe symptoms in adults after 12 weeks.
Several studies have shown that most people with severe psoriasis who are treated with infliximab (Remicade) have significant improvement in symptoms by week 10.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes of Short-Term or Tra...
- Causes of Chronic Insomnia...
- Risk Factors
- Prognosis
- Diagnosis
- Treatment
- Medications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Sedative Hypnotic Drug Warnings
In March 2007, the FDA ordered stronger warning labels on sedative hypnotic drugs. These medications include benzodiazepine and non-benzodiazepine drugs, such as zolpidem (Ambien), eszopiclone (Lunesta), ramelteon (Rozerem), and triazolam (Halcion). The FDA warned that these drugs may be associated with:
- Severe allergic reactions (anaphylaxis) and severe facial swelling (angioedema), which can occur even the first time a drug is taken
- Complex sleep-related behaviors, such as sleep driving, making phone calls, and preparing and eating food while asleep
Patients who take sleeping pills should be sure to follow the directions.
- 5 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Complications
- Symptoms
- Diagnosis
- Dietary Factors
- Treatment
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
FDA Issues Labeling Changes for Drugs That Boost Red Blood Cells
In November 2007, the U.S. Food and Drug Administration (FDA) made several changes to the prescribing labels for erythropoiesis-stimulating drugs. These drugs -- epoietin alfa (Epogen, Procrit) and darbepoetin alfa (Aranesp) -- increase the production of red blood cells.
- 0 Comments